Clinical Trial Update: A Phase 1b, Single Center, Clinical Study to Investigate the Safety and Biological Responses to Baminercept in Patients With Chronic HCV Hepatitis. [Phase 1]

View source ↗

Summary

Phase 1b, single-center trial evaluating the safety and biological responses to Baminercept in patients with chronic hepatitis C, with unknown trial status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Baminercept (baminercept)

Snippet

Sponsor: University of Zurich | Conditions: Chronic HCV Hepatitis C | Phase 1 | Status: UNKNOWN